Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.

Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment

NCT02708355 ·Status: COMPLETED ·Phase: PHASE4

Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib

NCT00365313 ·Status: COMPLETED ·Phase: PHASE3

Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients

NCT00699725 ·Status: COMPLETED

Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults

NCT01139190 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control

NCT00713947 ·Status: WITHDRAWN ·Phase: PHASE4

Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population

NCT03118778 ·Status: COMPLETED

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

NCT00700687 ·Status: COMPLETED ·Phase: PHASE1

Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

NCT00542789 ·Status: COMPLETED ·Phase: PHASE3

Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients

NCT00153660 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer

NCT01138969 ·Status: COMPLETED ·Phase: PHASE2

Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00241553 ·Status: COMPLETED ·Phase: PHASE3

Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)

NCT01128127 ·Status: WITHDRAWN ·Phase: NA

To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin

NCT00442052 ·Status: COMPLETED ·Phase: PHASE1

Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00241540 ·Status: COMPLETED ·Phase: PHASE3

Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00241527 ·Status: COMPLETED ·Phase: PHASE3

A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

NCT00626535 ·Status: COMPLETED ·Phase: PHASE3

Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

NCT00241514 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users

NCT02342470 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Effects of Acid Reducing Agents on Pharmacokinetics of PC14586 in Healthy Participants

NCT06054464 ·Status: COMPLETED ·Phase: PHASE1

A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

NCT00441519 ·Status: COMPLETED ·Phase: PHASE1

Nexium Capsules LDA Specific Clinical Experience Investigation

NCT01729182 ·Status: COMPLETED

Effect of a Proton Pump Inhibitor on the PK of Tepotinib

NCT03531762 ·Status: COMPLETED ·Phase: PHASE1

AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers

NCT00325715 ·Status: COMPLETED ·Phase: PHASE1

A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients

NCT03284177 ·Status: COMPLETED ·Phase: PHASE2

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

NCT02423187 ·Status: COMPLETED